Oral Abstract Session
Parallel Session 13: Next-generation strategies in cell and gene therapy 2

|
Room: Hall A2-3
Track: N/A

Presentations

Dr. Carole Guillonneau, France
Advancing CD8+ Treg cell therapy to the clinic for the treatment of kidney transplanted patients

Dr. Denis Efimov, Belarus
Clinical implementation of advanced biotechnologies for liver failure management in Belarus: stem cell therapies and tissue engineering approaches

Prof. Kenichi Yamahara, Japan
Exploratory physician-initiated clinical trial for innovative angiogenic therapy using injectable cell scaffold (ICS-001) with peripheral blood mononuclear cells for chronic limb threatening ischemia

Dr. Masayuki Kuroda, Japan
Autologous transplantation of LCAT gene-transduced adipocytes enabled long-term LCAT replacement in a patient with LCAT deficiency in first in human clinical trial

Dr. Shin Enosawa, Japan
First‑in‑human trial of the treatment with human embryonic stem (ES) cell-derived hepatocyte-like cells for infantile urea cycle disorders

Email: info@ctrms2025.org
514-874-1717